These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20446577)

  • 1. [Metabolic syndrome].
    Gotoda T
    Nihon Rinsho; 2010 May; 68(5):827-31. PubMed ID: 20446577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
    Cull CA; Jensen CC; Retnakaran R; Holman RR
    Circulation; 2007 Nov; 116(19):2119-26. PubMed ID: 17967769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome].
    Gimeno-Orna JA; Molinero-Herguedas E; Lou-Arnal LM; Boned-Juliani B; Labrador-Fuster T; Guiu-Campos M
    Rev Esp Cardiol; 2007 Nov; 60(11):1202-5. PubMed ID: 17996182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and microangiopathy.
    Szalat A; Raz I
    Isr Med Assoc J; 2006 Jun; 8(6):424-5. PubMed ID: 16833174
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.
    Leiter LA; Lundman P; da Silva PM; Drexel H; Jünger C; Gitt AK;
    Diabet Med; 2011 Nov; 28(11):1343-51. PubMed ID: 21679231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendations of Croatian societies on treatment of macrovascular and microvascular complications in patients with metabolic syndrome and diabetes type 2--treatment of residual risk].
    Reiner Z; Bozikov V; Car N; Knezević A; Kokić S; Metelko Z; Milicić D; Polić S; Zaputović L; Zjacić-Rotkvić V
    Lijec Vjesn; 2009; 131(1-2):1-3. PubMed ID: 19348347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome: in need of a global mission statement.
    Cameron AJ; Zimmet PZ; Shaw JE; Alberti KG
    Diabet Med; 2009 Mar; 26(3):306-9. PubMed ID: 19317827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and risk stratification of patients with the metabolic syndrome and diabetes.
    Wong ND
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):181-90. PubMed ID: 16509814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular complications in diabetes mellitus.
    Sobel BE; Schneider DJ
    Curr Opin Pharmacol; 2005 Apr; 5(2):143-8. PubMed ID: 15780822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].
    Nadal JF; Gutiérrez PC
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():7-13. PubMed ID: 24444518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: possibility for correction and prevention].
    Shishkova VN
    Ter Arkh; 2015; 87(1):109-114. PubMed ID: 25823279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic control and macrovascular complications of type 2 diabetes.
    Dandona P; Chaudhuri A
    Natl Med J India; 2008; 21(6):271-4. PubMed ID: 19691214
    [No Abstract]   [Full Text] [Related]  

  • 17. [Atherosclerosis in diabetes mellitus].
    Yamada N
    Nihon Rinsho; 2006 Nov; 64(11):1985-90. PubMed ID: 17087287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance.
    Stern M
    Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
    Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
    Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic complications in type 1 diabetes mellitus. Analysis of a cohort of 291 patients with a mean evolution time of 15 years].
    Chillarón JJ; Sales MP; Sagarra E; Castells I; Benaiges D; Flores Le-Roux JA; Pedro-Botet J
    Rev Clin Esp; 2012 Sep; 212(8):375-82. PubMed ID: 22765958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.